Showing 1,801 - 1,820 results of 32,495 for search '(( 50 ((((mean decrease) OR (a decrease))) OR (nn decrease)) ) OR ( e point decrease ))', query time: 1.00s Refine Results
  1. 1801
  2. 1802
  3. 1803

    Nestin expression is decreased in differentiated NSCs. by Emiliano Biasini (330033)

    Published 2013
    “…<p>(A) NSCs grown in complete media have high levels of nestin expression (green), which decreased after 10 days in differentiation media. …”
  4. 1804
  5. 1805

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…An OR to the left of the solid line represents a reduction in risk. (a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”
  6. 1806
  7. 1807

    Example of skyline query for proteins. by Rizka Fatriani (17485787)

    Published 2024
    “…<i>paniculata</i> in treating obesity showed that there was a significant decrease in PPARG and EP300 gene expressions in 3T3-L1 mature adipocytes treated with <i>M</i>. …”
  8. 1808

    Top 10 pathways with the lowest p-value. by Rizka Fatriani (17485787)

    Published 2024
    “…<i>paniculata</i> in treating obesity showed that there was a significant decrease in PPARG and EP300 gene expressions in 3T3-L1 mature adipocytes treated with <i>M</i>. …”
  9. 1809

    Pseudocode of block-nested loop (BNL). by Rizka Fatriani (17485787)

    Published 2024
    “…<i>paniculata</i> in treating obesity showed that there was a significant decrease in PPARG and EP300 gene expressions in 3T3-L1 mature adipocytes treated with <i>M</i>. …”
  10. 1810

    Top 10 gene ontologies with the lowest p-value. by Rizka Fatriani (17485787)

    Published 2024
    “…<i>paniculata</i> in treating obesity showed that there was a significant decrease in PPARG and EP300 gene expressions in 3T3-L1 mature adipocytes treated with <i>M</i>. …”
  11. 1811
  12. 1812
  13. 1813
  14. 1814
  15. 1815
  16. 1816
  17. 1817

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  18. 1818
  19. 1819
  20. 1820